The institutional cluster is too small in dollar terms to be a meaningful signal. Monitor upcoming ReMEDy2 interim analysis in early 2027 as the primary catalyst; the Q2 earnings beat and Phase 2 data are already priced in. The lack of insider buying suggests management is not signaling conviction at current levels.
Executive Summary
A mixed institutional cluster in DMAC for Q2 2026 shows 5 small buyers (net +$525K) versus 3 sellers (net -$579K), with Morgan Stanley's large trim dominating the sell side. The buying is from small asset managers doubling small positions, while the selling is concentrated in a single large passive manager. The cluster follows the company's Q2 earnings beat and positive Phase 2 preeclampsia data, but the aggregate dollar amounts are tiny relative to the $360M market cap, suggesting limited conviction from the institutional base. The lack of insider buying corroboration weakens the signal further.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$54.0K
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Bank Of Montreal /Can | DOUBLED | +194.8% | $387.0K | $261.0K |
| Citigroup | DOUBLED | +811% | $122.0K | $109.0K |
| Hightower Advisors | ADD | +55.2% | $120.0K | $46.0K |
| Russell Investments Group | DOUBLED | +243.2% | $65.0K | $46.0K |
| Deutsche Bank | ADD | +28.1% | $256.0K | $64.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -55.5% | $714.0K | -$383.7K |
| Pnc Financial Services Group | TRIM | -26.3% | $129.00 | -$30.00 |
| Nuveen | TRIM | -38.9% | $536.0K | -$195.2K |
Key Facts
- 5 institutional buyers added a net $525K in new positions, led by Bank of Montreal (DOUBLED, +$261K) and Citigroup (DOUBLED, +$109K)
- 3 institutional sellers reduced by a net $579K, with Morgan Stanley alone trimming $384K (55.5% of its position)
- Total net institutional flow was essentially flat at -$54K across 8 funds
- No open-market insider buying was detected in the window, weakening the cluster's conviction
- The cluster follows Q2 2026 earnings (EPS beat by 5%) and positive Phase 2 preeclampsia data for DM199
Financial Impact
8 institutions moved a net -$54K in aggregate: $949K in buying vs $1.0M in selling, representing less than 0.3% of market cap
Risk Factors
- Institutional activity is negligible relative to market cap — the cluster may be noise from small portfolio rebalancings
- Morgan Stanley's large trim could indicate a loss of confidence from a major holder, though it may also be passive index rebalancing
- No insider buying corroboration reduces the signal's reliability
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-DMAC-2026-Q2 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 15, 2026 10w ago | Institutional Cluster | $6.62 $6.53 | ▼ −1.36% | ▲ +0.62% | — |
Aug 10, 2026 11w ago | 8-K | $6.87 $6.59 | ▼ −4.08% | ▼ −3.02% | — |
Jun 11, 2026 19w ago | Institutional Cluster | $5.46 $7.71 | ▲ +41.21% | ▲ +39.32% | — |
May 6, 2026 24w ago | 8-K | $6.53 $5.65 | ▲ +13.48% | ▲ +16.61% | — |
Apr 1, 2026 29w ago | DEFA14A | $6.48 $6.05 | ▼ −6.64% | ▼ −16.51% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers